NEW YORK (GenomeWeb News) - Ciphergen Biosystems this week said it had no revenue in the first quarter of 2007, while R&D spending was down 23 percent and net loss improved by 12 percent.
 
The company also said its planned name change to Vermillion will take effect on Aug. 27, when it also will begin trading under the symbol VRML.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.